Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Oxaliplatin in Patient-Derived Cancer Assembloids
2026-08-11
Oxaliplatin research is moving beyond tumor-cell monocultures. This article explains how patient-matched gastric cancer assembloids can reveal stromal effects on DNA damage responses, drug sensitivity, and resistance assay design.
-
High-Throughput BBB Permeability Model Explained
2026-08-11
Hu et al. developed a Transwell blood-brain barrier surrogate that combines LLC-PK1-MOCK and LLC-PK1-MDR1 cells with lysosomal trapping correction. Across 41 compounds, the model linked in vitro permeability with unbound brain distribution and provided a practical framework for distinguishing passive diffusion, P-glycoprotein efflux, and intracellular sequestration during early CNS drug screening.
-
Safe DNA Gel Stain for Safer Nucleic Acid Workflows
2026-08-10
Safe DNA Gel Stain supports sensitive DNA and RNA visualization while helping laboratories reduce dependence on ethidium bromide and UV exposure. This practical guide connects safer gel imaging with cloning workflows, vesicle-assay development, and troubleshooting decisions that protect sample integrity.
-
Recombinant Human IL-15: Assay Workflow Guide
2026-08-09
Build reproducible T-cell and NK-cell experiments with a tag-free, high-potency cytokine and a structured titration workflow. This guide also shows how immune-cell assays can complement, but not replace, neural-circuit studies of early-life adversity and innate defensive behavior.
-
Amitriptyline HCl: Protocol and QC Guide
2026-08-08
Amitriptyline HCl (SKU B2231) provides a defined hydrochloride salt for controlled neurotransmitter receptor modulation, signal-transduction, and neuropharmacology research workflows. It is appropriate for in vitro assay development and pharmacological comparison, but dossier potency values should not be treated as universal results or as evidence of therapeutic efficacy, blood-brain barrier performance, or disease-model benefit.
-
MTT Assay Reagent: Mechanism and Workflow
2026-08-07
MTT is a tetrazolium-based reagent for in vitro cell proliferation, metabolic activity measurement, and colorimetric cell viability assays. Its purple formazan signal reports cellular reducing activity, so interpretation requires controls that separate metabolic changes from changes in cell number.
-
Transmission Dynamics of Carbapenemases in Enterobacter cloa
2026-08-07
This study analyzes the prevalence and genetic transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong, China. The findings highlight the dominance of blaNDM-1, multidrug resistance patterns, and the efficient horizontal transfer of resistance determinants, providing critical insight for Gram-negative bacterial infection research and future containment strategies.
-
HotStart Universal 2X Green qPCR Master Mix: Precision for G
2026-08-06
Unlock robust, reproducible gene expression quantification with HotStart™ Universal 2X Green qPCR Master Mix. This dye-based qPCR solution from APExBIO streamlines antioxidant research, offering unmatched specificity, instrument compatibility, and workflow simplicity.
-
Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Variant Adaptat
2026-08-06
Shukla et al. present a high-throughput infection assay leveraging multiplexed ACE2 libraries to map the shifting compatibility between SARS-CoV-2 spike variants and host ACE2 orthologs. Their findings demonstrate that ongoing viral evolution expands the spectrum of ACE2 variants utilized for entry, with important implications for cross-species transmission and viral adaptation studies.
-
Surrogate In Vitro Model Enhances BBB Permeability Predictio
2026-08-05
A new high-throughput in vitro model using LLC-PK1-MOCK/MDR1 cells integrates lysosomal trapping correction, enabling accurate blood-brain barrier (BBB) permeability prediction. This innovation strengthens early CNS drug screening, reducing reliance on animal models and facilitating the identification of brain-penetrant compounds.
-
Safe DNA Gel Stain: Advancing Translational Nucleic Acid Det
2026-08-05
This thought-leadership article explores the mechanistic, technical, and strategic underpinnings of adopting Safe DNA Gel Stain in translational molecular workflows. By contextualizing its safety and sensitivity within the broader landscape of nucleic acid visualization, and bridging evidence from both bench and clinical research, we offer translational scientists actionable guidance for risk-mitigated, data-driven nucleic acid detection.
-
Talabostat Mesylate: Unveiling DPP4 and FAP Inhibition in Pr
2026-08-04
Explore how Talabostat mesylate (PT-100) uniquely advances cancer research by targeting DPP4 and FAP to influence protein stability and tumor microenvironment modulation. Discover actionable, science-driven insights beyond typical inhibitor reviews.
-
Cimetidine: Optimizing BBB and Cancer Research Workflows
2026-08-04
Cimetidine, a distinctive histamine-2 receptor antagonist, empowers high-fidelity in vitro blood-brain barrier and gastrointestinal cancer research. Its unique partial agonist profile, robust solubility, and APExBIO-verified purity unlock advanced assay reproducibility and translational insight.
-
HACC-TNF-α-VLP Nanoparticles Enable Hsp90-Driven CD8+ Immuni
2026-08-03
The referenced study introduces HACC-TNF-α-VLP nanoparticles that leverage Hsp90-dependent antigen cross-presentation to boost both CD8+ T cell and mucosal immune responses against foot-and-mouth disease virus. These findings provide a mechanistically informed platform for improving cellular and mucosal vaccine efficacy, with broad implications for immunomodulatory nanoparticle design.
-
PPACK Dihydrochloride: Defining Precision in Platelet Pathwa
2026-08-03
Explore how PPACK Dihydrochloride enables unprecedented precision in dissecting platelet and thrombin signaling. This in-depth analysis uniquely bridges chemical mechanism, assay optimization, and practical workflow decisions for advanced blood coagulation research.